Berkeley Capital Partners, LLC Novartis Ag Transaction History

Berkeley Capital Partners, LLC

$326 Million
Q1 2024

A detailed history of Berkeley Capital Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Berkeley Capital Partners, LLC holds 18,152 shares of NVS stock, worth $1.93 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

18,152

Previous 6,259 190.01%

Holding current value

$1.93 Million

Previous $631,000 178.13%

% of portfolio

0.54%

Previous 0.21%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$95.27 - $108.47 $1.13 Million - $1.29 Million	11,893 Added 190.01%	18,152 $1.76 Million
Q4 2023 Feb 09, 2024	SELL	$92.27 - $101.54 $16,424 - $18,074	-178 Reduced 2.77%	6,259 $631,000
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $24,535 - $27,228	-259 Reduced 3.87%	6,437 $655,000
Q2 2023 Aug 03, 2023	SELL	$92.52 - $104.91 $911,969 - $1.03 Million	-9,857 Reduced 59.55%	6,696 $675,000
Q1 2023 May 02, 2023	BUY	$80.03 - $92.81 $18,486 - $21,439	231 Added 1.42%	16,553 $1.52 Million

Q4 2022 Feb 10, 2023	BUY	$75.55 - $92.52 $52,885 - $64,764	700 Added 4.48%	16,322 $1.48 Million
Q3 2022 Nov 04, 2022	BUY	$74.61 - $87.26 $114,526 - $133,944	1,535 Added 10.9%	15,622 $1.19 Million
Q2 2022 Aug 04, 2022	BUY	$80.52 - $93.75 $123,195 - $143,437	1,530 Added 12.18%	14,087 $1.19 Million
Q1 2022 May 05, 2022	BUY	$80.11 - $90.62 $697,998 - $789,572	8,713 Added 226.66%	12,557 $1.1 Million
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $78,185 - $86,455	981 Added 34.26%	3,844 $336,000
Q3 2021 Nov 04, 2021	BUY	$81.78 - $95.14 $5,315 - $6,184	65 Added 2.32%	2,863 $234,000
Q2 2021 Aug 16, 2021	SELL	$85.24 - $94.15 $14,320 - $15,817	-168 Reduced 5.66%	2,798 $255,000
Q1 2021 May 04, 2021	BUY	$83.5 - $98.47 $11,940 - $14,081	143 Added 5.07%	2,966 $254,000
Q4 2020 Jan 28, 2021	BUY	$78.07 - $94.43 $1,951 - $2,360	25 Added 0.89%	2,823 $267,000
Q3 2020 Nov 03, 2020	SELL	$82.14 - $91.0 $10,349 - $11,466	-126 Reduced 4.31%	2,798 $243,000
Q2 2020 Jul 30, 2020	SELL	$80.93 - $91.1 $8,335 - $9,383	-103 Reduced 3.4%	2,924 $255,000
Q1 2020 Apr 21, 2020	SELL	$70.67 - $99.01 $17,667 - $24,752	-250 Reduced 7.63%	3,027 $250,000
Q4 2019 Jan 24, 2020	SELL	$84.35 - $95.37 $2,277 - $2,574	-27 Reduced 0.82%	3,277 $310,000
Q3 2019 Nov 01, 2019	SELL	$85.54 - $94.26 $10,606 - $11,688	-124 Reduced 3.62%	3,304 $287,000
Q2 2019 Aug 08, 2019	SELL	$75.4 - $92.8 $1,885 - $2,320	-25 Reduced 0.72%	3,428 $313,000
Q1 2019 Apr 30, 2019	BUY	$75.32 - $86.15 $7,908 - $9,045	105 Added 3.14%	3,453 $332,000
Q4 2018 Jan 28, 2019	BUY	$73.66 - $82.02 $4,419 - $4,921	60 Added 1.82%	3,348 $287,000
Q3 2018 Oct 30, 2018	BUY	$66.94 - $77.43 $220,098 - $254,589	3,288 New	3,288 $283,000
Q4 2017 Feb 02, 2018	SELL	$72.33 - $77.64 $192,759 - $206,910	-2,665 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$74.14 - $77.27 $197,583 - $205,924	2,665	2,665 $229,000

Others Institutions Holding NVS

# of Institutions

1,343

Shares Held

140M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $229B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkeley Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Berkeley Capital Partners, LLC with notifications on news.

Account

Berkeley Capital Partners, LLC Novartis Ag Transaction History